共 50 条
- [32] Ness-Abramof Rosane, 2005, Timely Top Med Cardiovasc Dis, V9, pE31
- [35] Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (07): : 761 - 775
- [38] SCHEEN AJ, 2005, 65 ANN SCI SESS AM D